Summary
The extent of propranolol protein binding was determined in three different age groups of healthy drug-free caucasian males. Volunteers selected for study were 6–15 years old, 25–36 years old and 68–76 years old. Ten milliliters of blood were obtained via venipuncture and collected in glass tubes from the subjects after an overnight fast. Binding determinations were performed by equilibrium dialysis using radiolabelled propranolol. Serum albumin and α1-acid glycoprotein concentrations were determined in all subjects by radial immunodiffusion. The results obtained showed wide intersubject variability in the binding ratio of propranolol and serum concentrations of α1-acid glycoprotein. Mean albumin serum concentration was found to be significantly lower in the elderly group as compared to the adult and pediatric groups (p<0.02). A positive correlation was found between the binding ratio of propranolol and the serum concentration of α1-acid glycoprotein in all the subjects (r=+0.66,p<0.005). No significant correlation was found between the binding ratio of propranolol and the serum concentration of albumin (r=−0.03,p<0.88). These data suggest that the extent of propranolol binding is influenced primarily by serum concentrations of α1-acid glycoprotein and not by differences in age.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Jusko WJ, Gretch M (1976) Plasma and tissue protein binding of drugs. Pharmacokinet Drug Metab Rev 5: 43–140
Shoeman DW, Azarnoff DL (1975) Diphenylhydantoin potency and plasma protein binding. J Pharmacol Exp Ther 195: 84–86
Anton AH (1975) The relationship between the binding of sulfonamides to albumin and their antibacterial efficacy. J Pharmacol Exp Ther 195: 84–86
McDevitt DG, Frisk-Holmberg M, Hollifield JW, Shand DG (1976) Plasma binding and the affinity of propranolol for a beta receptor in man. Clin Pharmacol Ther 20: 152–157
Piafsky KM, Borga O (1977) Plasma protein binding of basic drugs. II. Importance of α1-acid glycoprotein for interindividual variation. Clin Pharmacol Ther 22: 545–549
Sager G, Nilsen OG, Jacobsen S (1979) Variable binding of propranolol in human serum. Biochem Pharmacol 28: 904–911
Nilsen OG, Jacobsen S (1975) The binding of quinidine to protein fractions of normal human sera. Biochem Pharmacol 24: 995–998
Evans GH, Nies AS, Shand DG (1973) The disposition of propranolol, decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. J Pharmacol Exp Ther 186: 114–122
Piafsky KM, Borga O, Odar-Cederlöf I et al. (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease induced elevations of plasma α1-acid glycoprotein. N Engl J Med 299: 1435–1439
Sager G, Hansteen V, Aakesson I, Jacobsen S (1981) Effect of heparin on serum binding of propranolol in the acute phase of myocardial infarction. Br J Clin Pharmacol 12: 613–620
Scott BJ, Bradwell AR, Schneider RE, Bishop H (1979) Propranolol binding to serum orosomucoid. Lancet 1: 930
Glasson S, Zini R, D'Athis P et al. (1979) The distribution of bound propranolol between the different human serum proteins. Mol Pharmacol 17: 187–191
Mather LE, Tucker GT, Pflug EA et al. (1975) Meperidine kinetics in man: intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 17: 21–30
Hayes MJ, Langman MJS, Short AH (1975) Changes in drug metabolism with increased age, Phenytoin clearance and protein binding. Br J Clin Pharmacol 2: 73–79
Wallace S, Whiting B, Runcie J (1976) Factors affecting binding in plasma of elderly patients. Br J Pharmacol 3: 327–330
Hayes MJ, Langman MJS (1975) An analysis of carbenoxolone plasma binding and clearance in young and elderly people. In: Avery, Jones, Parke (eds) Fourth Symposium on Carbenoxoline. Butterworths, London, pp 107–114
Miller AK, Adir J, Vestal RE (1977) Effect of age on the pharmacokinetics of tolbutamide in man. Pharmacology 19: 128
Greenblatt DG, Allen MD, Hartmatz JS, Shader RI (1980) Diazepam disposition determinants. Clin Pharmacol Ther 27: 301–312
Cammarata RJ, Rodnan GP, Fennell RH (1967) Serum anti globulin and anti nuclear factors in the aged. J Am Med Assoc 199: 115–118
Greenblatt DJ (1979) Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 27: 20–23
Owen DB (1962) Handbook of statistical tables. Addison-Wesley, Reading, MA, pp 41–45
Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State University Press, Ames, IA
Freely J, Crooks J, Stevenson IH (1981) The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. Br J Clin Pharmacol 12: 73–78
Gersovitz M, Munro HN, Vdell J et al. (1980) Albumin synthesis in young and elderly subjects using a new stable isotope methodology: response to level of protein intake. Metabolism 29: 1075–1086
Misra DP, Loudon JM, Staddon GE (1975) Albumin metabolism in elderly patients. J Gerontol 30: 304–306
Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–388
Castleden CM, Genge CG (1979) The effect of aging on the hepatic clearance of propranolol. Br J Clin Pharmacol 7: 49–54
Wilson JT, Atwood GF, Shand DG (1976) Disposition of propoxyphene and propranolol in children. Clin Pharmacol Ther 19: 264–270
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bendayan, R., Pieper, J.A., Stewart, R.B. et al. Influence of age on serum protein binding of propranolol. Eur J Clin Pharmacol 26, 251–254 (1984). https://doi.org/10.1007/BF00630294
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00630294